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Spectral Cross Correlation as a Supervised Approach for the Analysis of Complex Raman
Datasets: The Case of Nanoparticles in Biological Cells
Mark E. Keating*, Franck Bonnier, Hugh J. Byrne,
Focas Research Institute, Dublin Institute of Technology, Kevin Street, Dublin 8, Ireland,

Abstract
Spectral Cross-correlation is introduced as a methodology to identify the presence and
subcellular distribution of nanoparticles in cells. Raman microscopy is employed to
spectroscopically image biological cells previously exposed to polystyrene nanoparticles, as a
model for the study of nano-bio interactions. The limitations of previously deployed strategies of
K-means clustering analysis and principal component analysis are discussed and a novel
methodology of Spectral Cross Correlation Analysis is introduced and compared with the
performance of Classical Least Squares Analysis, in both unsupervised and supervised modes.
The previous study demonstrated the feasibility of using Raman spectroscopy to map cells and
identify polystyrene nanoparticles in a lipid rich environment, which is suggestive of the
membrane rich endoplasmic reticulum. However, short comings in identification of all
nanoparticle signatures in the cell using K-means clustering are apparent, as highlighted by
principal component analysis of the identified clusters which demonstrates that K-means
clustering does not identify all regions where spectral signatures of the nanoparticles are evident.
Thus, two more sophisticated analytical approaches to the extraction of the nanoparticle
signatures from the Raman spectral data sets, namely classical least squares analysis and cross
correlation analysis, were employed and are demonstrated to improve the identification of
spectroscopic signatures characteristic of polystyrene nanoparticles in a cellular environment.
Additionally, to investigate the local biochemical environment in which the nanoparticles are

trafficked, a pure spectrum of 3-sn-phosphatidyl ethanolamine was cross correlated against the
Raman data set, further suggesting the particles are indeed localized in a lipid rich environment.
Furthermore, to demonstrate the robustness and versatility of the analysis method, a spectrum of
pure RNA was used to demonstrate that a differentiation could be made between DNA of the
nucleus and RNA of the nucleolus using the supervised spectral cross-correlation technique.

Keywords: Raman Spectroscopy, NanoParticles, Intracellular localisation, Multivariate analysis,
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Introduction
Nanotechnology is set to become the first trillion dollar industry in history, with predicted
benefits which span a wide range of fields, including applications in site specific delivery of
drugs in humans, to antimicrobial paint coatings and textile finishing, to advances in the
electronics industry
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. However, there are caveats associated with deploying these

nanotechnologies which must be addressed before true realistic applications can be widely
accepted and adopted as the norm.
It is widely known that nanomaterials, more specifically nanoparticles, possess a range of
unique characteristics which in some ways dictate their usefulness and applicability in fields
such as medical science. Properties such as increased surface to mass ratio result in an increased
reactivity and associated novel optical properties result in new possibilities in diagnostic and
theranostic imaging and delivery7,8, while novel semi-conductor properties are applicable to the
electronics industry9. However, these properties also potentially have negative implications, most
importantly in terms of the potential impact of nanoparticle exposure on human health and the
environment. Nanoparticles have been demonstrated to be taken up by cells in vitro and to elicit
a toxic response while many reports exist of adverse toxic effects in vivo10–15.
One of the challenges facing the nanotoxicology community is the detection and
monitoring of the interaction mechanisms of nanoparticles in cells16,17. Currently, fluorescent
microscopy is the most widely used and accessible method to study nanoparticle uptake and
trafficking18–23. Necessarily, however, it relies on the use of inherently fluorescent or labelled
compounds for visualization and monitoring of nanoparticles inside cells. Most nanoparticles are
not intrinsically fluorescent, however, and it has been recently demonstrated that fluorescent

labels can be labile, and that the observation and distribution of intracellular fluorescence
following nanoparticle exposure is not necessarily representative of the presence or distribution
of nanoparticles in the cell24. While it is also possible to study the dynamics of nanoparticle
trafficking using label free optical microscopic techniques such as dark field and differential
interference contrast (DIC) microscopy, the techniques are mainly applicable to metal particles
such as gold and silver.25 Transmission electron microscopy (TEM) provides an additional
method by which nanoparticles can be visualised in a cellular environment26–28. The high lateral
resolution obtainable with TEM renders it an ideal method for visualising sub cellular organelles
and uptake and interaction of nanoparticles. However, significant sample processing (fixing and
ultramicrotoming) is required and only particles with sufficient electronic contrast to the cellular
environment can be visualised28,29
Thus, a label-free technique is required which can ideally unambiguously identify the
presence of the nanoparticles in the cells, their sub-cellular location, and their overall effect on
the cellular metabolism. Raman spectroscopy is one such method which may provide an alternate
to traditional approaches for studying the nanoparticle-biological interface. The technique
provides not only a label free method to visualize how the nanoparticle behaves in a biological
environment, but offers the potential to identify the local environment and simultaneously
analyse the associated metabolic changes. To do this, one must combine Raman spectroscopy
with analytical data mining approaches to extract the signatures associated with the nanoparticles
but also to probe the environment the particles are localized in, and to correlate the exposure and
subcellular interaction mechanisms with the metabolic changes.
Previous studies have indicated the potential of Raman as a label free method for
studying biological processes. Examples include novel approaches for cervical cancer

diagnostics30, to investigating the effects following exposure to human papilloma virus (HPV)
infection31, the effects of chemotherapeutic anticancer agents in cells32,33, live cell
analysis34,35and the toxic responses to single walled carbon nano-tubes (SWCNT), to name but a
few36.
Surface enhanced Raman scattering (SERS) is also a potential method to study the
intracellular dynamics of nanoparticle trafficking and compartmentalisation37,38. However, only
certain types of nanoparticle, such as gold and silver particles and nanoaggregates have the
potential to generate SERS spectra, thus limiting the technique to the study of only a certain type
of nanoparticles. Additionally the surface enhancement process and molecular specificity of the
technique are not fully understood, which may lead to ambiguity in the understanding of cellular
trafficking.
A more recent study indicated the ability of Raman spectroscopy to detect the presence of
intracellular polystyrene nanoparticles39. Polystyrene was chosen as a model nanoparticle for the
study as it is commercially available and regularly employed as a standard in nanotoxicology
(particularly as a positive control in its aminated form). Furthermore, the conjugated styrene ring
makes it a relatively strong Raman scatterer. However, while the identification is somewhat
straight forward, the presence of overlapping peaks in both the polystyrene and cellular spectra
(e.g. both cellular and polystyrene spectra exhibit a strong symmetric ring breathing peak at
~1004cm-1) presents a challenging system with which to validate the effectivity of the
experimental and data analysis techniques. K-means clustering analysis (KMCA) analysis was
used to differentiate regions of the cell as well as to identify and localise the nanoparticles.
Analysis of the local cellular environment of the detected nanoparticles was performed via a
comparison between loadings obtained from principal component analysis (PCA) and pure

spectra of lipids and polystyrene nanoparticles. However, when the data was analyzed using
PCA, it was noted that the clusters detected using KMCA failed to identify all regions which
contained the spectral fingerprint corresponding to polystyrene in a biological environment.
Furthermore, the average spectra of the cluster identified by KMCA, while containing features
clearly characteristic of polystyrene, also contained spectral features of the neighbouring cellular
environment. Analysis of the loading of the principal components provided a clearer
differentiation of the nanoparticle contributions from the local cellular environment, but neither
unsupervised technique provided an unambiguous localisation of the target species 39.
Other multivariate analytical approaches have also been applied in the field of Raman
microspectroscopy of cells. In addition to KMCA, other clustering methods such as Fuzzy C
means clustering (FCM) and hierarchal cluster analysis (HCA) have been used to separate the
cellular Raman data into clusters and subsequently reshape the data into images40,41. However, as
highlighted by Headegaad et al., these approaches have their own limitations. In particular
boundaries between sub-cellular features can often result in the addition of extra clusters with
mixed spectral signatures. This addition can be overcome by increasing the number of clusters;
however, this in turn can result in added complexity to interpretation and inaccuracies in regional
seperation. Additionally, the reproducibility of these methods can also be questioned as the
starting point for the centroid based KMCA and FCM is subjective40.
PCA and vertex component analysis (VCA) have also been used to separate out distinct
regions of the cell. With regards to PCA, separation is based on the variances between the
spectra in the data set, the majority of the variance being described by the first three principal
components40. Thus, the score values can be used to construct a composite image of the cell in
which the biochemical contributions of each component are described by the corresponding

loadings plot. Unlike KMCA and FCM, PCA identifies quite accurately the boundaries between
each feature. However, the images generated suffer from inferior contrast and in some instances
interpretation may be difficult as biochemical features may be spread across different loadings.
VCA is another method which has been used for similar analytical purposes. In brief,
VCA computes a linear combination of supposed pure component spectra which are termed
endmember spectra. As described in Miljkovic et al., the endmember spectra are acquired under
the assumption that the most extreme data points in the dataset are representative of pure
component spectra41. However, it has been pointed out that the endmembers generated are not
truly representative of the pure component they describe in the data set and can often contain a
mixture of biochemical constituents i.e. DNA and proteins42. While this is representative of the
true nature of nucleic acids in-situ, it could lead to inaccuracies in interpretation.
The work presented here demonstrates the potential of a Spectral Cross Correlation
Analysis (SCCA) for the analysis of Raman spectral datasets. The method is applied to the
dataset of Dorney et al. 39, of polystyrene nanoparticles in A549 lung adenocarcinoma cells, and
is thus compared with previous analyses by KMCA and PCA. The performance of SCCA is also
compared to that of classical least squares analysis (CLSA), performed both in a supervised and
unsupervised manner, which allows for a direct comparison between both approaches. SCCA
utilises the spectrum of the target chemical component and cross correlates the spectrum with
that of the complete Raman spectral dataset. The quantitative performance is demonstrated using
simulated datasets and the potential is demonstrated by mapping the spatial profile of the
polystyrene nanoparticles in the cells as well as other biochemical components of the cell, (RNA
and lipids).

Experimental

Sample Preparation for Raman Imaging

A549 Cells were seeded at a density of 4 x 104 cells onto calcium fluoride (CaF2) windows
(Crystran Ltd., UK) for confocal Raman imaging. The cells were incubated for 24 hrs in
Dulbecco’s Modified Eagle’s Medium (DMEM F12), supplemented with 10% foetal calf serum
(FCS) and 1% L-Glutamine at 37°C, 5% CO2. Following cell adherence, 2 mLs of medium
containing 1x 1012 nanoparticles per mL were added to the cells. The cells and nanoparticles
were incubated for 24hrs at 37°C and 5% CO2. Following nanoparticle exposure, the cells were
washed in warm PBS three times and fixed for 10mins in 10% buffered formalin. After fixation,
the cells were washed to remove any trace of fixative and kept in NaCl solution prior to imaging.
Component spectra used in SCCA were generated as described in Bonnier and Byrne 201243. For
polystyrene nanoparticle spectra, nanoparticle suspension was added drop-wise to a CaF2
window and allowed to air dry prior to Raman acquisition. RNA from baker’s yeast
(saccharomyces cerevisiae) was added to water and subsequently deposited on a CaF2 window
and allowed to air dry. 3-sn-phosphatidyl ethanolamine was dispersed in chloroform and
deposited on CaF2 windows.

Confocal Raman Spectroscopic Imaging
Confocal Raman Spectroscopic Imaging was performed using a Horiba Yobin-Yvon LabRAM
HR800 spectrometer with a 785nm, 300mmW diode laser as source and a Peltier cooled 16-bit

CCD. A 100X, N.A. 1.2, (LUMplanF1, Olympus) water immersion objective was used for all
cellular measurements. The confocal pin hole of the system was set to 100µm, the recommended
setting for confocal operation, to allow optical sectioning of the sample. A 300 lines per mm
spectroscopic grating, providing a dispersion of ~1.5cm-1 per pixel, was used and the system was
pre-calibrated to the spectral line at 520.7cm-1 of silicon. Using an automated programmable
stage, Raman spectra of the cell were acquired with a 0.75µm step size over a 29*39 pixel area
which encompassed the nuclear, perinuclear and cytoplasmic regions of the cell.
Data Pre-Processing and Preparation
In order to prepare the data for analysis, a number of steps were taken to ensure the spectra in the
map were of a high enough quality to give accurate results. For CLSA, all data pre-processing
was carried out using Labspec 5 software which comes as standard on the Raman instrument.
Firstly, a background spectrum which constituted the contribution of the CaF2 substrate and
water in the imaging medium was subtracted from each spectrum in the mapped data set.
Following subtraction of the background spectrum, a Savitsky-Golay smoothing filter (5th order,
7 points), available on the software, was used to lightly smooth the data. The data was then
baseline corrected using a nodal point baseline correction using the minimum amount of points
possible to ensure minimal alteration of the acquired data. Normalization was carried out
automatically by the software during CLSA.
Data was prepared in a similar fashion for SCCA. However, the pre-processing was
carried out in Matlab (Mathworks,USA) using previously published protocols for data
processing39. As outlined above, a background spectrum was subtracted from the Raman data set
to remove the substrate and immersion medium contributions. A Savitsky-Golay smoothing filter

(5th order, 7 points) was applied to the data and a nodal point baseline correction was used to
baseline the data using a minimum amount of reference points to do so. Preparation of
component spectra for SCCA was done in the same manner for polystyrene, RNA and lipids.

Classical Least Squares Analysis
CLSA was carried out using Labspec 5 software which comes as standard on the Raman
spectrometer software. The analysis method is based on a fit of a linear combination of reference
component spectra to the spectra contained in the raw spectral map. This is described by
Equation 1, for the case where three reference component spectra are used. S is the sum of the
linear contribution of the reference components (A, B, C), and x, y, z are the respective
weightings or scores necessary for the weighted sum of the reference component spectra to
match the raw data.
S = [x*A] +[y*B] + [z*C]

Equation 1

Using the software, there are two different ways to obtain the reference component spectra. The
first way is to obtain a pure spectral reference from a compound or compounds which can then
be fitted according to Equation 1. The second method uses a factor analysis algorithm to generate
the component spectra, the weighted sum of which is compared to the Raman spectral data set.
Using the latter of the two methods, Zavaleta et al demonstrated the power of the technique to
quantify quantum dot accumulation in an in-vivo mouse model and to separate out the different
spectral contributions from complex SERS signals in the same data set44. In a similar and
different way, both approaches to CLSA are explored to extract spectra which contain
polystyrene nanoparticles and define other biochemical regions such as the RNA and lipid rich

environments. The relative contributions of the different components are defined by the
weighting factors (x, y, z….).

Spectral Cross Correlation Analysis
For SCCA, reference spectra from polystyrene, phosphatidyl-ethanolamine and RNA (Figure
1A) were used to screen the Raman spectral data set. All SCCA was carried out using Matlab
(Mathworks, USA) using the “crosscorr” function available in the signal processing toolbox.
Equation 2 describes the cross correlation between two data series, where C(x) is the correlation
function, S(τ) is the Raman spectrum in the data set to be tested and A(x+τ) is the reference
spectrum i.e. polystyrene, lipid or RNA. The function integrates the product of the two data
series (spectra) at each point as they are shifted relative to each other along the x axis (wave
number). The magnitude of the correlation quantifies the relative contribution of the component
spectrum at that point in the cell, and an exact correlation occurs when the spectra are exactly
matched (auto-correlation). In this way, it is possible to screen the map or spectra in the map and,
based on the cross correlation function, cluster different biochemical regions of the cell based on
the relative contributions of the reference spectrum used.
∞

C( X ) =

∑ S (τ ).A( X + τ )

Equation 2

m = −∞

Simulated Data
Simulated data sets were used to test the robustness and sensitivity of both CLSA and SCCA in
their ability to detect spectral contributions due to polystyrene, RNA and lipid in a biological

environment. To generate the simulated data sets, a cellular spectrum was used as a template to
which varied amounts of component spectrum were added. Keeping the cellular spectrum
constant, a series of 38 simulated spectra of ratios 1:1 to 1:10-4, cellular: component Raman
spectra for polystyrene, RNA and lipid were generated (Figure 1A). An example of the simulated
data set for polystyrene is shown in Figure 1B, which shows the addition of the first 8 spectral
dilutions to the constant cellular spectrum. Using these simulated datasets, it was possible to
explore how each data mining approach performs when testing experimental data and thus
facilitate accurate interpretation of the data sets.

Figure 1. (A) Component spectra of nano-polystyrene (dotted line), 3-sn-phosphatidyl
ethanolamine (dashed line) and isolated RNA (solid line), offset for clarity. (B) Shows an
example of the first eight simulated spectra for polystyrene in cells, offset for clarity. Each
spectrum consists of a constant cellular spectrum with a varied concentration of polystyrene
added to it, with decreasing polystyrene concentration from top to bottom. Simulated data sets
generated in this way were then analysed by CLSA and SCCA.
Results
Simulated Data – Unsupervised CLSA
CLSA can be carried out in two different ways, either by generating spectral models using a
factor analysis algorithm (unsupervised), or by manually inputting the component spectra
(supervised). The data in Figure 2 shows the results using the factor analysis generated models
for simulated data sets generated based on cellular/polystyrene, RNA and lipid spectra (Figure 1
B). In each instance, the score recorded form CLSA for each spectrum is plotted against the
component concentration added to the data set. In all cases, the extracted CLSA scores
accurately represent the true component ratios over the concentration range, represented by the
solid line. The results depart from nonlinearity a cellular:component ratio of ~1:0.1, after which
the CLSA weightings no longer accurately reflect the correct component weighting, although the
presence of the component can still be identified in ratios as low as 1:0.03.

Figure 2. CLSA of simulated spectral data sets of nano
nano-polystyrene,
polystyrene, RNA and lipid. In each
graph, the score from the CLSA
A is plotted against the concentration of component spectrum
added to a constant cellular spectrum (points on each graph). The solid black line represents the
ideal response which gives an indi
indication
tion of the quantitative nature of the technique.

Single Cell Data – Unsupervised CLSA

In order to further test the ability of CLS
CLSA to identify intracellular polystyrene nanoparticles
located inside a single cell Raman map, an initial factor analysis algorithm was applied to the
data set to generate 7 model spectra
ectra to be used in the CLSA
CLSA. These model spectra were then used
to compute the scores from the Raman data set (Fig
(Figure 3A). It is then possible to segment the

cell into different distributions based on specific spectral differences as shown in Figure 3B. The
spectral profile of each model contribution can be visualized individually showing the percentage
contribution at each pixel (Figure 3C-F). A more detailed look at the model spectra generated
and corresponding cellular distribution can be seen in Figure 4A-G.
The CLSA map shows a different spatial distribution of each model in the Raman
spectral data set. Although in all cases, the model spectra show strong contributions of the
cellular environment, they are differentiated by contributions from distinct components. Model 1
(Figure 4A) shows characteristic peaks corresponding to those seen in pure polystyrene spectra
(see Figure 1A). Therefore, the pixel distribution of model 1 is deemed to show the localisation
of the polystyrene nanoparticles, indicating a perinuclear distribution in the cell, consistent with
the K-means cluster analysis of Dorney et al39. Other models show a different distribution in the
cell. Model 6 shows a distribution which visually corresponds to the nucleolus of the cell (Figure
4B), whereas model 3 surrounds the nucleoli and is identified as the nucleus of the cell (Figure
4E). This shows the ability of CLSA to differentiate the biochemical regions of the cell
containing RNA and DNA. Other models such as model 4 (Figure 4C) and model7 (Figure 4F)
show a distinct distribution surrounding the nucleus, which may correspond to perinuclear
organelles such as the endoplasmic reticulum or the Golgi apparatus which are lipid rich regions
of the cell.

Figure 3: Clustering of spectra identified by unsupervised CLS
CLSA.. (A) Spectral models generated
from the analysis protocol and used to generate the clustered map shown in (B). The right panel
(C-I)
I) shows the distribution of each model created in the map. Of particular note,
note model 1(C),
model 6(D) and model 7(H) have strong contributions of the spectra of polystyrene, RNA and
lipid respectively. The spectra in (A) are col
colour
our coded and correspond to images (B – F), with
the exception of Model 6 which corresponds to the white image in (D).

Figure 4: A closer look at the generated model spectra created by CLSA (A--G). The overlap
between pixels corresponds to a percentage contribution from each particular model. In some
instances a pixel may contain 50% of one model and 50% of another, which is highlighted
somewhat by the intensity of the pixel, although this is visually subjective.

Simulated Data - Supervised CLS
CLSA
Unsupervised CLSA is clearly a powerful technique to analyse the subcellular structure and to
identify the presence and distribution of nanoparticles. However, it should be noted that the
technique does not yield pure spectra of the components (compare for example Figure 4A with

the pure spectrum of polystyrene in Figure 1A), and the respective models are mixtures of
spectral signatures of the components and the background cellular spectrum. A secondary
approach to CLSA which provides a more supervised approach was therefore also tested. In a
similar way, the simulated datasets were used to assess the technique prior to testing the real
Raman cellular map.
The simulated data sets generated to test the unsupervised factor analysis algorithm model
generation approach to CLSA were used again to test the supervised approach which uses
component spectra of polystyrene, RNA and lipid as the model spectra to generate scores for
each spectrum in the data set. In the simulated data shown in Figure 5, it is observed that it is
possible to identify a trend similar to that seen in Figure 2 for the unsupervised CLSA. For RNA
and lipid, the trend matches well the predicted response for concentrations as low as 1:0.1,
whereupon it deviates from linearity, falling to zero at a ratio of~1:0.03. However, for
polystyrene, although the trends are similar, the results are deviate from the predicted response
much earlier than the unsupervised CLSA. This indicates that the identification of the
components using a supervised CLSA approach may not be as accurate as the model generation
approach shown in Figure 3. Thus, to test this prediction and for comparison, supervised CLSA
was carried out on the same cellular data set using polystyrene, RNA and lipid spectra as the
cellular components used to generate the scores for CLSA.

Figure 5. Supervised CLSA of simulated spectral data sets of nano
nano-polystyrene,
polystyrene, RNA and lipid.
In each graph, either the pure spectrum of polystyrene, RNA or lipid was used to calculate the
CLSA score. This score was then plotted against the concentra
concentration
tion ratio of pure component
spectrum: cellular spectrum used to generate the simulated data set
set.

Single Cell Data - Supervised CLS
CLSA
In order to compare the different CLS
CLSA approaches, the cellular Raman data set was screened
using three pure component spectra individually, nano-polystyrene,
polystyrene, RNA and lipid. The aim was
to use these spectra to generate the CLS
CLSA scores and thuss identify regions of the cell which

correspond to each spectrum, identifying different regions of the cell based on their biochemical
composition and also where the nanoparticles were situated.
The spectra and corresponding score maps are shown in Figure 6 A – C. Figure 6A
shows a spectrum of polystyrene which was used to screen the map and corresponding visual
image of the distribution of nano-polystyrene in the cell. In the image, it is observed that the
polystyrene is present in every spectrum in the cell, albeit in differing amounts based on the pixel
intensity at each point. This is not consistent with the model generated CLSA above or with
previously published data which show the polystyrene to be localised in clusters surrounding the
nucleus39. However, the regions of high intensity most likely correspond to the areas which
contain the nanoparticles.
Similarly this method for assessing the distribution of RNA and lipids in the cell does not
quite reproduce the results observed above for CLSA using the unsupervised factor analysis
algorithm. Again, it is observed that the distribution of lipid and RNA is throughout the Raman
map of the cell, which, while more plausible for lipids, does not make biological sense for the
RNA. Therefore, again it must be concluded that the supervised CLSA approach is prone to
error, although it is still possible to compare regions of high intensity to the output of the
unsupervised CLSA images above. An arbitrary threshold can be applied to the dataset, as is
shown for the three component spectra in the right hand panels of Figure 6A-C. Using this
method, the spatial distributions of the components matches well that of the unsupervised CLSA.
However this threshold is ambiguous and it is not possible to say from the simulated data at what
value an accurate representation of the biochemical distribution in the cell is achieved.

(A),, RNA (B) and (C) 3-sn3
Figure 6: Supervised CLSA using component spectra of polystyrene (A)
phosphatidyll ethanolamine. The spectrum of each pure component is shown on the left of the
graph,, with the corresponding to non
non-thresholded
thresholded data shown in the middle and arbitrarily
thresholded data shown on the right.

Simulated data –Spectral Cross Correlation Analysis
The observations in Figure 6 that supervised CLSA contained a high level of error in the Raman
images prompted a search for an alternate supervised approach to screening Raman data sets
which could be used to unambiguously identify regions of the cell which correspond to the pure
component spectrum of interest chosen, be that polystyrene, RNA, lipid or any other spectral
signature which may be of interest. A novel technique was thus investigated for the analysis of
Raman maps, which uses cross correlation as a method to investigate the presence or absence of
a component in a complex Raman data set in a supervised manner. Thus, SCCA was used to
screen the same simulated and real data sets for the presence of polystyrene, RNA and lipid for
comparison which both methods of CLSA.
Spectral cross correlation analysis (SCCA) was initially investigated using the same simulated
data sets that were used to investigate both CLSA approaches. Similar to the supervised CLSA
approach, pure component spectra were used to screen each data set for the presence of each in
their respective simulated data set. Figure 7 compares the results of the simulated SCCA for each
of the different components polystyrene, lipid and RNA. In all cases, a correlation of the SCCA
co-efficient and the true concentration ratios is observed, but to varying degrees of accuracy.
For polystyrene, a minimum correlation coefficient value of ~ 0.3 is reached at a
concentration ratio of cellular: polystyrene spectrum of ~ 1:0.1. This indicates that at this
concentration ratio, the presence of the polystyrene spectral fingerprint cannot be distinguished
from the cellular spectrum. Thus, for the practical implications of screening a cell for polystyrene
nanoparticles, correlation coefficient values at or below 0.3 represent the cellular peaks which

overlap with characteristic polystyrene peaks and thus values below this are deemed not to be
nanoparticles. This hypothesis was tested using a blank Raman map which contained no
polystyrene data in (data not shown) and a value of correlation of 0.3125 was determined, which
is close to the predicted value in the simulated data sets. This indicates the need to threshold
cellular data in order to identify polystyrene nanoparticles in the cell.
A similar performance was observed for both RNA and lipid simulated data sets, where
an initial decrease in the correlation coefficient was observed in relation to concentration ratio of
pure component: cell spectrum. Again a minimum baseline correlation coefficient was observed
for both RNA and lipid simulated SCCA data. Notably, however, this value was different, in
both cases higher, than that observed for polystyrene, possibly due to an increased overlap of
Raman bands present in the lipid and RNA spectra with cellular Raman bands in comparison to
the polystyrene spectrum. In the case of the lipid contribution, the correlation with the predicted
response is quantitatively poor even at ratios above 1:0.1. However, this can possibly be
explained by lipid contributions already present in the cellular spectrum and/or the relatively
broad lipid bands present in the lipid spectrum used.
The next step was to investigate the performance of SCCA in a real Raman data set of the
cell. Thus the previous map was screened in a supervised manner to investigate if nanopolystyrene could be identified in the Raman map. Additionally, the lipid spectrum was used to
see if the local cell environment could be investigated. Also, as used in the above supervised
CLSA, RNA was used to see if a differentiation could be made between the nucleus and
nucleolus.

Figure 7. SCCA carried out on simulated data sets containing added polystyrene, RNA
RN and lipid
component spectra. In each instance
stance, a pure component spectrum of polystyrene, RNA and lipid
lip
was cross correlated against each data set to investigate the performance of the technique. The
solid line shows the idealised response
response.
Single Cell Data –SCCA
SCCA was used to screen the Raman data set for the presence of polystyrene, RNA and lipid
distributions. The spectra and correlation maps are shown in Figure 8. In figure 8A,
8A the spectrum
of polystyrene is shown in red and the corresponding correlation map is shown adjacent for both
thresholded (right) and non-thresholded
thresholded (left) datasets. This map shows the distribution of
polystyrene nanoparticles in the Raman map. Importantly
Importantly, the threshold which was predicted
from the simulated data,, or more simply from a cross
cross-correlation of the component spectrum
with the raw average cellular spectrum, was applied to the data set and returned a map which

corresponded to the previously observed Raman image from the unsupervised CLSA (Fig 4A).
Notably, however, the spectrum is the pure spectrum of polystyrene, rather than a
cellular/polystyrene mixture. This result shows the capability for a supervised approach for the
unambiguous identification of polystyrene nanoparticles in complex Raman spectroscopic data
sets.
Furthermore, to investigate how SCCA can be used to probe the local cellular
environment, the lipid spectrum was used to screen the data set (Fig 8B). Again applying a
threshold to the data set it is possible to identify regions of the cell which contain a high density
of lipids using a supervised approach to Raman analysis. Thus it is possible to investigate the
local cell environment to which the nanoparticles are trafficked after 24hrs. This is consistent
with the previous K-means cluster analysis

39

which suggests that indeed the nanoparticles are

located in a highly lipid rich environment.
As an additional demonstration of the potential of SCCA, a pure RNA spectrum was
cross correlated against the data set to see if it was possible to differentiate spectra which
corresponded to the nucleolus of the cell and thus differentiate between DNA and RNA rich
regions of the cell. Figure 8C shows that it is possible to identify the nucleolus of the cell using
cross correlation analysis. It was also observed that a high correlation coefficient was present in
regions outside the nucleus. This could possibly correspond to cytoplasmic ribosomal RNA
(rRNA) or cytoplasmic messenger RNA (mRNA). Thus a novel approach for extracting complex
spectral information from Raman data sets is demonstrated in SCCA.

Figure 8: SCCA
CCA analysis using component spectra of polystyrene (A)
(A), 3-sn-phosphatidyl
3
ethanolamine (B) and RNA (C).. The spectrum of each pure component is shown on the left of
the figure and the correlation map
maps for non-thresholded
thresholded shown in the middle and thresholded on
the right.

Discussion
Raman spectroscopy is a powerful tool for the investigation of biological samples. Previous
studies have shown the capability of the technique to investigate sub cellular structures and
processes which provide Raman images comparable to images observed usi
using
ng wide-field
wide
and

confocal fluorescent microscopy45,46,35,39,47. Notably, however, Raman spectroscopy is a label
free method which provides a visualization of the biochemical make up of a cell without costly
and time consuming processing with reagents, and when combined with appropriate analysis
methods can provide a wealth of information pertaining to biological processes in the cell. The
aim of this paper was thus to investigate two analytical approaches both in an unsupervised and
supervised approach and assess their ability to identify polystyrene nanoparticles and
biochemical distributions in a single cell Raman map.
Unsupervised CLS analysis is demonstrated to be capable of identifying the presence of
nanoparticles in regions of the cell. However, while this method is valuable for identifying
distributions in the cell, the model spectra generated in this manner must be further analysed to
extract any real biochemical information. Therefore, while the analysis of the simulated dataset
in figure 2 indicates that the unsupervised model has a higher accuracy, the model spectra
yielded by the unsupervised CLS analysis do not directly compare to the pure component spectra
shown in Figure 1 and therefore cannot be used to unambiguously identify the contributing
components.
In contrast, employing supervised approaches to the analysis of Raman data sets allows
for the spectral array to be screened directly with the nanoparticle or pure biochemical
component spectrum of interest. Analysis in this way enables a direct screening of the cellular
distribution of a particular component while simultaneously probing the chemical or biochemical
environment of the particular location in the cell. CLSA and SCCA are both used in a supervised
approach for analysing Raman cellular data sets (Figure 6 and Figure 8). However,
unthresholded, both show a degree of error for all three components tested (nano-polystyrene,
RNA and Lipids). To correct for this, a threshold can be applied to both CLSA and SCCA.

Importantly, this threshold should not be applied in an arbitrary manner, as this facilitates a loss
of information from the dataset. While thresholding for supervised CLSA is arbitrary and
subjective, the simulated datasets generated for SCCA provided a good estimation of where this
thresholding should take place and in combination with cellular data containing no nanoparticles
it was possible to accurately reveal where the nanoparticles were located in the cell. It should be
noted that the thresholding level appears to be dependent on the spectral profile of the individual
component, as it is dependent on the degree of similarity of the spectrum of the target component
with that of the environment. Incorrect correction of spectral background may also add to the
threshold. On the other hand the simulated data for supervised CLSA did not provide a threshold
value to apply to the dataset and thus was arbitrarily thresholded, which is far from ideal to gain
any reliable information about the dataset. Therefore, SCCA provides a more reliable supervised
approach for identification of nanoparticles and other biological components when used in
combination with a threshold generated by simulated datasets.

In addition, quantitative

information can be extracted from the simulated data sets, with each of the three approaches
showing some level of quantification based on how well the matched the predicted response,
with SCCA showing the highest level of sensitivity of the three techniques. SCCA is specifically
a supervised approach, as it is necessary to provide the pure component spectrum. However, it is
conceivable the technique could be extended to a library of reference spectra which could in turn
be screened against the data set in an unsupervised manner.

Conclusions
CLSA and SCCA are shown to be two methods capable of identifying intracellular polystyrene
nanoparticles and also to probe the local biochemical environment the nanoparticles are

trafficked to within the cell. CLSA is a relatively straight forward method for analysing
spectroscopy data sets. However, SCCA is demonstrated in the simulated data sets to be a more
sensitive approach for nanoparticle identification. It is envisaged that both these and other
supervised methods will provide analytical approaches which can be used not only as
identification methods for other nanoparticles inside cells and detection of resultant biochemical
changes, but also to provide alternate analytical approaches to the study of other processes such
as chemotherapeutic response of cells to drugs. Additionally the full quantitative nature of these
analytical approaches will need to be explored if Raman spectroscopy is to become a routine
application in the study of nano-bio interactions and beyond.
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